Literature DB >> 28302047

Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer's and Parkinson's Diseases.

Jordan A McKenzie1, Lindsay J Spielman1, Caitlin B Pointer1, Jessica R Lowry1, Ekta Bajwa1, Carolyn W Lee1, Andis Klegeris1.   

Abstract

BACKGROUND: Alzheimer's Disease (AD) and Parkinson's Disease (PD) are among the most common causes of dementia, which increasingly contribute to morbidity and mortality worldwide. A common hallmark in the pathogenesis of these two diseases is neuroinflammation, which is initially triggered by the presence of pathological structures associated with these disorders. Chronic neuroinflammation is sustained by persistent and aberrant microglial activation in the brain, which results in damage and death of neighboring cells, including neurons and glial cells. Two types of risk factors contribute to the development of AD and PD: non-modifiable risk factors and modifiable risk factors. Non-modifiable risk factors include genetic susceptibility that increases an individual's risk of developing the disease, whereas modifiable risk factors include a wide variety of health- and lifestyle-related factors that may be altered by changing individual behaviors.
METHOD: Ovid Medline and PubMed databases were used to perform an ordered search of the peerreviewed research literature described in this review.
RESULTS: This review focuses on four modifiable risk factors including physical inactivity, vascular disease-related conditions, obesity and type two diabetes mellitus, all of which have been identified as risk factors for the development of AD and PD.
CONCLUSION: We highlight that control of the modifiable risk factors is a valid approach for managing the increased incidence of AD and PD. We describe neuroinflammatory mechanisms, which are common to AD and PD that may link both these neurodegenerative diseases with the four common modifiable risk factors. Understanding neuroinflammatory mechanisms could help identify novel therapeutic targets for combating these neurodegenerative diseases. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Physical inactivity; dementia; hypertension; microglia; obesity; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2017        PMID: 28302047     DOI: 10.2174/1874609810666170315113244

Source DB:  PubMed          Journal:  Curr Aging Sci        ISSN: 1874-6098


  26 in total

1.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

Review 2.  Neuroimmunology of the female brain across the lifespan: Plasticity to psychopathology.

Authors:  R M Barrientos; P J Brunton; K M Lenz; L Pyter; S J Spencer
Journal:  Brain Behav Immun       Date:  2019-03-11       Impact factor: 7.217

3.  State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

Authors:  Kaleen M Lavin; Paul M Coen; Liliana C Baptista; Margaret B Bell; Devin Drummer; Sara A Harper; Manoel E Lixandrão; Jeremy S McAdam; Samia M O'Bryan; Sofhia Ramos; Lisa M Roberts; Rick B Vega; Bret H Goodpaster; Marcas M Bamman; Thomas W Buford
Journal:  Compr Physiol       Date:  2022-03-09       Impact factor: 8.915

4.  Clustering of Alzheimer's and Parkinson's disease based on genetic burden of shared molecular mechanisms.

Authors:  Mohammad Asif Emon; Ashley Heinson; Ping Wu; Daniel Domingo-Fernández; Meemansa Sood; Henri Vrooman; Jean-Christophe Corvol; Phil Scordis; Martin Hofmann-Apitius; Holger Fröhlich
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

5.  Alterations of the Viable Ileal Microbiota of the Gut Mucosa-Lymph Node Axis in Pigs Fed Phytase and Lactic Acid-Treated Cereals.

Authors:  Jutamat Klinsoda; Julia Vötterl; Qendrim Zebeli; Barbara U Metzler-Zebeli
Journal:  Appl Environ Microbiol       Date:  2020-02-03       Impact factor: 4.792

Review 6.  Visit-to-visit variability in blood pressure and Alzheimer's disease.

Authors:  Simona Lattanzi; Francesco Brigo; Fabrizio Vernieri; Mauro Silvestrini
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-25       Impact factor: 3.738

7.  Blood pressure variability and neurocognitive functioning.

Authors:  Simona Lattanzi; Fabrizio Vernieri; Mauro Silvestrini
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-21       Impact factor: 3.738

8.  Revealing the Modular Similarities and Differences Among Alzheimer's Disease, Vascular Dementia, and Parkinson's Disease in Genomic Networks.

Authors:  Yafei Chen; Qiong Liu; Jun Liu; Penglu Wei; Bing Li; Nongyun Wang; Zhenquan Liu; Zhong Wang
Journal:  Neuromolecular Med       Date:  2021-06-12       Impact factor: 3.843

9.  Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and Controls.

Authors:  Jonas Bacelis; Michele Compagno; Sonia George; J Andrew Pospisilik; Patrik Brundin; Åsa Torinsson Naluai; Lena Brundin
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

Review 10.  Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson's Disease.

Authors:  Joanna A Motyl; Joanna B Strosznajder; Agnieszka Wencel; Robert P Strosznajder
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.